feed,title,long_url,short_url
Motley,Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?,https://www.fool.com/investing/2024/03/17/madrigal-pharmaceuticals-stock-screaming-buy/?source=iedfolrf0000001,https://da.gd/WlnaM4
